Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab
Active, not recruitingOBSERVATIONAL
Enrollment
148
Participants
Timeline
Start Date
March 2, 2022
Primary Completion Date
March 31, 2026
Study Completion Date
March 12, 2026
Conditions
Asthma in Children
Interventions
DRUG
Mepolizumab
Treatment with Mepoluzimab
Trial Locations (1)
SE5 9RS
King's College Hospital, London
All Listed Sponsors
lead
King's College Hospital NHS Trust
OTHER
NCT05139381 - Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab | Biotech Hunter | Biotech Hunter